COGT
Cogent Biosciences·NASDAQ
--
--(--)
--
--(--)
COGT Filings
Filing Date
Form Description
Form Type
2026-01-30
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-30 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-22
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-22 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-22
Form 144 - Report of proposed sale of securities
Ownership
2026-01-22 · Ownership
Form 144 - Report of proposed sale of securities
2026-01-22
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-01-22 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-01-21
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-21 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-21
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-21 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-12-30
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-30 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-30
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-30 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-30
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-30 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-30
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-30 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
